-

RWS’s Language Technology Sets New Industry Benchmark – a Trillion Words Translated in the Past Year

Redefining what’s possible with AI-powered global understanding

MAIDENHEAD, England--(BUSINESS WIRE)--RWS, a content solutions company, powered by technology and human expertise, has shattered a major AI translation milestone: translating one trillion words in just 12 months through its language technology platform. To put that into perspective, it’s the same as handling the entire digital knowledge base of a Fortune 500 company - every single hour.

This achievement – powered by RWS’s industry-leading language technology platform that includes Language Weaver and Trados – marks a new era in enterprise-grade, highly scalable multilingual communication.

Translating one trillion words in a year is more than a number. It demonstrates the accelerating impact of AI in enterprise communication. Enterprises are turning to language AI and embedding scale, security and specializations deep into their enterprise content ecosystems and technology stacks – amplifying the value of their content investments globally.

“Reaching this incredible milestone is proof that RWS continues to unlock global understanding for our clients,” said Christina Scott, Chief Product and Technology Officer, RWS. “It also showcases the unrivalled impact of RWS’s industry-leading technologies, which combine AI innovation with human expertise, to redefine what’s possible in multilingual content.”

With one trillion words and counting, RWS is just getting started – investing in the future of language AI; making global understanding faster, smarter and more human.

About us

RWS is a content solutions company, powered by technology and human expertise. We grow the value of ideas, data and content by making sure organizations are understood. Everywhere.

Our proprietary technology, 45+ AI patents and human experts help organizations bring ideas to market faster, build deeper relationships across borders and cultures, and enter new markets with confidence – growing their business and connecting them to a world of opportunities.

It’s why over 80 of the world’s top 100 brands trust RWS to drive innovation, inform decisions and shape brand experiences.

With 60+ global locations, across five continents, our teams work with businesses across almost all industries. Innovating since 1958, RWS is headquartered in the UK and publicly listed on AIM, the London Stock Exchange regulated market (RWS.L).

More information: rws.com

Contacts

RWS
Denis Davies
Corporate Communications
ddavies@rws.com
+44 1628 410105

RWS

LSE:RWS

Release Versions

Contacts

RWS
Denis Davies
Corporate Communications
ddavies@rws.com
+44 1628 410105

More News From RWS

RWS Secures US Patent for AI That Predicts Translation Effort at the Point of Authoring

MAIDENHEAD, England--(BUSINESS WIRE)--RWS (RWS.L), a global AI solutions company, has been awarded US Patent No. 12,505,297 for an AI-powered system that enables organizations to understand the translation potential of their content as it is being authored – long before a translation project is scoped or commissioned. Coming to Trados customers in 2026, the patented technology – Document Translation Feasibility Analysis Systems and Methods – analyzes a source document to identify how much conte...

RWS Wins ‘Outstanding IP Service Team in China’ Award for Fourth Straight Year

MAIDENHEAD, England--(BUSINESS WIRE)--RWS (RWS.L), a global AI solutions company, has been named Outstanding IP Service Team in China 2025 at the Enterprise IP Strategy Forum and Annual Conference of In-house IP Managers in Beijing. The recognition marks the fourth consecutive year that RWS’s team in China has received the award, following wins in 2022, 2023 and 2024. Judged on professional capability, business processes and intellectual property research expertise, the award also reflects the...

RWS Launches New CNS Rater Training Service to Strengthen Data Quality in Clinical Trials

MAIDENHEAD, England--(BUSINESS WIRE)--RWS (RWS.L), a global AI solutions company, announces the launch of a new rater training, certification and retraining service designed specifically to improve data quality, consistency and reliability in central nervous system (CNS) clinical trials. The new service helps pharmaceutical sponsors and clinical research organizations (CROs) reduce one of the biggest risks in CNS studies: variability in how clinical raters assess patients. Even small difference...
Back to Newsroom